NIH-funded research R01 grant

Metabolite biomarkers to spot and classify osteoarthritis early

Official title: Metabolomic Profiling to Identify Candidate Biomarker Profiles and Molecular Endotypes for Osteoarthritis

Funded at Montana State University - Bozeman · NIH-11145222 · Data updated 2026-11-12

Looks at whether patterns of small molecules in joint fluid and blood can spot and classify osteoarthritis earlier in people with joint pain.

More Osteoarthritis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMontana State University - Bozeman
NIH-funded
Lab location1 site (Bozeman, United States)
Project startAugust 10, 2023
Project endJuly 31, 2028
Funding year2025
Award (this year)$431,753
NIH project number5R01AR081489-03
Project IDNIH-11145222 on NIH RePORTER

Who could benefit from this research

Could help

Adults with suspected or diagnosed knee or hip osteoarthritis who are willing to provide blood and, when clinically appropriate, joint (synovial) fluid samples.

Less likely to help

People without osteoarthritis, those with other inflammatory joint diseases, or anyone unwilling or unable to provide blood or joint fluid samples are unlikely to benefit from participation.

What this research studies

Researchers will collect synovial (joint) fluid and blood plasma from people with different degrees of osteoarthritis and analyze small-molecule (metabolite) patterns using advanced metabolomics techniques. They will compare metabolite profiles to clinical measures and imaging to find panels that track disease grade and distinct molecular subtypes (endotypes). The goal is to identify signatures that reveal early-stage OA or different biological forms of the disease. These findings would be used to guide future tests that could be done from a blood draw or joint sample.

Why it matters

Potential benefit: Could enable earlier diagnosis and more personalized treatment or monitoring for people with osteoarthritis.

How similar studies have gone: Metabolomics for osteoarthritis is a promising and active area of research with some supportive association studies, but no metabolite panel has yet been validated for routine clinical use.

Where this research is happening

  • Montana State University - Bozeman
    Bozeman, United States
    Active

Researchers

  • Principal investigator: June, Ronald Kent — Montana State University - Bozeman
  • Study coordinator: June, Ronald Kent

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.